Synthesis of DNA and poly(adenosine diphosphate ribose) in normal and chronic lymphocytic leukemia lymphocytes

N A Berger, J W Adams, G W Sikorski, S J Petzold, W T Shearer, N A Berger, J W Adams, G W Sikorski, S J Petzold, W T Shearer

Abstract

Peripheral blood lymphocytes were isolated from 9 patients with chronic lymphocytic leukemia (CLL) and 12 normal control donors. The cells were assayed for synthesis of DNA and poly-(adenosine diphosphate ribose) (poly[ADPR]) immediately after isolation and on successive days following their treatment with phytohemagglutinin (PHA). Two different techniques were used to measure DNA synthesis. In the standard technique, DNA synthesis was measured by incubating intact cells with [(3)H]deoxythymidine. In the new technique, the lymphocytes were first rendered permeable to nucleotides, then DNA synthesis was measured by incubating them with [(3)H]deoxythymidine triphosphate in the presence of deoxyATP, deoxyGTP, deoxyCTP, ATP, and Mg(++). Both assays showed the anticipated rise in DNA synthesis after PHA stimulation of normal cells. PHA-stimulated lymphocytes from patients with CLL demonstrated low levels of DNA synthesis in both assay systems. The initial levels of poly(ADPR) synthesis were greater in CLL lymphocytes than in normal cells. Studies with a T-cell-depleted population of normal cells showed the same activity for poly(ADPR) synthesis that was demonstrated by the original population of normal cells. PHA stimulation produced an increase in poly(ADPR) synthesis in both the normal and CLL cells. The increase in poly(ADPR) synthesis in normal cells was coincident with the increase in DNA synthesis. The increase in poly(ADPR) synthesis in the CLL cells was dissociated from the delayed and diminished increase in DNA synthesis. Thus, CLL cells have higher than normal initial levels of poly(ADPR) synthesis. Poly(ADPR) synthesis is dissociated from DNA synthesis in CLL cells whereas it varies directly with DNA synthesis in normal lymphocytes.

References

    1. J Clin Invest. 1975 Nov;56(5):1324-7
    1. J Biol Chem. 1967 Jul 10;242(13):3164-71
    1. Proc Soc Exp Biol Med. 1968 Mar;127(3):668-71
    1. Nature. 1977 Oct 20;269(5630):655-61
    1. J Mol Biol. 1975 Dec 5;99(2):317-37
    1. Blood. 1970 Feb;35(2):236-42
    1. Cancer Res. 1972 Feb;32(2):398-407
    1. J Natl Cancer Inst. 1977 Apr;58(4):1167-9
    1. Proc Soc Exp Biol Med. 1975 Sep;149(4):933-8
    1. Cancer Res. 1974 Dec;34(12):3197-202
    1. Methods Med Res. 1964;10:39-47
    1. Cold Spring Harb Symp Quant Biol. 1969;34:781-6
    1. Cancer Res. 1970 Nov;30(11):2636-44
    1. Blood. 1969 Oct;34(4):421-9
    1. FEBS Lett. 1971 Dec 15;19(3):244-246
    1. N Engl J Med. 1973 Jan 25;288(4):176-80
    1. Biochim Biophys Acta. 1975 Jun 16;395(2):191-200
    1. Transplant Rev. 1970;5:45-75
    1. J Clin Invest. 1972 Oct;51(10):2537-43
    1. Proc Soc Exp Biol Med. 1972 Dec;141(3):839-41
    1. Biochem J. 1975 Apr;147(1):119-29
    1. J Clin Invest. 1971 Apr;50(4):818-26
    1. J Exp Med. 1974 Jun 1;139(6):1553-67
    1. Annu Rev Biochem. 1977;46:95-116
    1. J Clin Invest. 1976 Mar;57(3):756-61
    1. Biochem Soc Trans. 1977;5(4):949-50
    1. Biochem Biophys Res Commun. 1970 Sep 10;40(5):1013-20
    1. Biochemistry. 1976 Jan 27;15(2):426-30
    1. Radiat Res. 1975 Sep;63(3):501-30
    1. Exp Cell Res. 1974 Jan;83(1):63-72
    1. Radiat Res. 1975 Apr;62(1):37-51
    1. Biochim Biophys Acta. 1976 Feb 18;425(1):1-17
    1. Radiat Res. 1963 Dec;20:600-18
    1. Biochim Biophys Acta. 1977 Sep 6;478(1):44-58
    1. Biochim Biophys Acta. 1975 Feb 10;378(3):333-43

Source: PubMed

3
Abonnieren